A drug for Alzheimer’s, called Leqembi, might soon be given less often. Right now, patients get it through a drip every two weeks. The idea is to change this to once a month.
Leqembi helps get rid of harmful proteins in the brain that can damage nerves and lead to memory problems.
The FDA is looking at this new once-a-month plan to see if it’s still safe and works well. If they say yes, it could make life easier for people with Alzheimer’s and those who take care of them. They wouldn’t have to go to the hospital as much for treatment.
Experts are still studying Leqembi to see how good it is in the long run. But so far, it seems to help slow down memory loss in people with early signs of Alzheimer’s.
The FDA will decide on this new plan by January 25, 2025.
Now, that’s great advancement in the treatment of Alzheimer’s. Yet what about treatment for patients with med to late term Alzheimer’s. I need a treatment plan for my family member now, as an caregiver. Please address this issue. Thanks~RSCGilbert